Immunomodulation by macrolides: therapeutic potential for critical care

Area of Science:

• Critical care medicine
• Immunology
• Pharmacology

Background:

• Critical illness causes immune dysregulation, leading to hyperinflammation and immune suppression.
• Hyperinflammation causes tissue damage and organ failure.
• Immune suppression increases susceptibility to secondary infections and viral reactivation.

Purpose of the Study:

• To review preclinical and clinical evidence on macrolides' beneficial effects in critical care.
• To discuss the mechanisms behind macrolides' immunomodulatory properties.
• To highlight the potential of macrolides in managing critical illness.

Main Methods:

• Overview of preclinical studies.
• Review of clinical trials.
• Discussion of proposed immunomodulatory mechanisms.

Main Results:

• Macrolides possess potent immunomodulatory properties.
• Evidence suggests beneficial effects in acute diseases relevant to critical care.
• Potential to correct immune dysregulation without hindering antimicrobial defenses.

Conclusions:

• Macrolides may offer therapeutic benefits for critically ill patients.
• Further research is needed to identify patient subgroups and optimize treatment.
• Development of novel, non-antibiotic macrolide derivatives is a promising avenue.